Table of Contents
What changed
Revenue (dividends and distributions received) fell 8.8% to $235.1m on the like-for-like extraction basis, with the release also citing a narrower 0.6% decline on a broader revenue-from-operating-activities measure of $262.8m. Profit before tax slipped 4.0% to $248.0m and NPAT declined 2.2% to $235.1m, cushioned by a lower effective tax rate (5.2% vs 6.9%). Operating cash flow was the standout move, down 29.8% to $178.8m from $254.6m, and the cash balance fell to $97.1m from $111.3m. Gross borrowings remained nil. Total assets rose 25.7% to $9.12bn and equity rose 21.1% to $7.56bn, overwhelmingly a mark-to-market move on the investment portfolio rather than an operating outcome. The final dividend was declared at 14.0 cents per share, unchanged from the prior final.
What matters
- Dividend income recovery is incomplete. The 8.8% fall in recognised dividend revenue reflects COVID-era payout cuts by portfolio companies still rolling through, and given AFI is an LIC its reported "revenue" is effectively the distribution pass-through from its holdings. PBT's milder 4.0% decline suggests supplementary income or timing partially offset this, but the underlying income engine is still below FY20.
- Cash conversion deteriorated sharply. OCF dropped $75.9m while NPAT fell only $5.3m — a divergence that materially weakens the quality of the headline result even if it largely reflects dividend-receipt timing rather than economic loss.
- Balance sheet strengthened on portfolio revaluation. Equity growth of $1.32bn dwarfs reported earnings and reflects market recovery in the investment book. Net cash position remains intact with zero drawn borrowings, so liquidity direction is weaker only at the margin.
Expectations
No FY22 guidance, stated targets, or forward-work indicators were disclosed. The second-half shape context is instructive: HY21 contributed only 35.6% of full-year NPAT and 40.9% of full-year revenue, making FY21 heavily second-half weighted. That pattern implies the income recovery accelerated through the second half — a directionally positive read for FY22 distribution flow if portfolio payouts continue normalising, but the release does not quantify that trajectory. The maintained 14cps final (with prior-year full-period DPS of 14.0 cents in the extraction, noting this is the final component only) was declared into a payout ratio of 72.3% of NPAT, up from 70.4%, leaving less headroom if dividend income doesn't recover.
Quality of result
The result is mixed. NPAT's modest decline flatters the underlying picture because a lower effective tax rate contributed, and the $9.12bn asset base and $7.56bn equity gain are portfolio revaluation, not earnings. The 29.8% OCF decline against a 2.2% NPAT decline is the clearest quality flag — cash receipts lagged accounting recognition by roughly $57m relative to the earnings move. For an LIC whose economic function is converting portfolio distributions into dividends to shareholders, that gap matters. On the durable side, the capital structure remains conservative (nil gross debt, $97.1m cash), ROE of 3.4% is consistent with the LIC model, and there is no evidence of non-recurring items or non-GAAP adjustments dressing the numbers.
Unresolved
- What drove the $75.9m OCF shortfall — dividend-receipt timing, special-dividend comparables, or portfolio repositioning proceeds?
- What was NTA per share at 30 June 2021? The release references it but the figure is not captured in the supplied extraction, leaving the premium/discount context unknowable here.
- Has the portfolio's underlying dividend run-rate recovered into H2 FY21 enough to sustain the 14cps final with a sub-75% payout next year?
- Was there a special-dividend component in the FY20 base that makes the headline revenue comparison harsher than the underlying trend?
This briefing cannot assess portfolio composition, concentration, or the market-value discount/premium at which AFI traded, because that disclosure is absent from the supplied data.
Key metrics
| Metric | FY21 | FY20 | Change |
|---|---|---|---|
| Revenue | $235.1m | $257.9m | -8.8% ↓ |
| Net profit after tax | $235.1m | $240.4m | -2.2% ↓ |
| Net cash inflow from operating activities | $178.8m | $254.6m | -29.8% ↓ |
| Declared dividend per share | — | 14.0c | — |
| Cash and cash equivalents | $97.1m | $111.3m | -12.8% ↓ |
| Total assets | $9115.0m | $7251.8m | +25.7% ↑ |
Reference: annolyse.ai/briefings/afi-fy21
Analytical metrics
| Metric | FY21 | FY20 | Context |
|---|---|---|---|
| PBT growth | -4.0% | — | — |
| Effective tax rate | 5.2% | 6.9% | — |
| Net debt | −$97.1m | −$111.3m | +$14.2m |
| Gross borrowings | $0.0m | — | — |
| Payout ratio vs NPAT | 72.3% | — | — |
| ROE (annualised) | 3.4% | 3.7% | Weakening |
| HY21 share of FY21 revenue | 36.6% | — | Other half was 63.4% |
| HY21 share of FY21 NPAT | 35.6% | — | Other half was 64.4% |
Reference: annolyse.ai/briefings/afi-fy21
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.